{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:59:28Z","timestamp":1790704768098,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","award":["Research Training Program Scholarship"],"award-info":[{"award-number":["Research Training Program Scholarship"]}],"id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","award":["Jaquot Research Entry Scholarships (2022RES00054 and 2023RES00139)"],"award-info":[{"award-number":["Jaquot Research Entry Scholarships (2022RES00054 and 2023RES00139)"]}],"id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","award":["G J 2002824 AMRF"],"award-info":[{"award-number":["G J 2002824 AMRF"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess the feasibility of a novel methodology for quantifying kidney-specific cell-free DNA (ks-cfDNA) and explore whether levels differed between individuals with preeclampsia (PE) and normotensive pregnant controls (NP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cell-free DNA (cfDNA) is released during cell death and circulates in bodily fluids, including urine. cfDNA quantities reflect the degree of organ injury. As PE is associated with hypertension and kidney injury, we hypothesised that urinary ks-cfDNA would be elevated in PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-centre prospective case-control study urine samples were collected from 20 women with PE and 20 NP controls. Digital PCR was used to quantify three kidney-specific epigenetic targets (ks-et): ks-et1 (pan-kidney marker), ks-et2 (renal proximal tubular epithelial cell (RPTEC) and podocyte marker) and ks-et3 (RPTEC marker). The beta-actin gene (ACTB) represented total cfDNA (t-cfDNA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ks-et2 and ks-et3 were higher in the PE group. Median ks-et2 was 231 copies\/mL (IQR 65\u2013383) versus 62 copies\/mL (IQR 29\u2013215) in NP controls (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.028). Median ks-et3 was 81 copies\/mL (IQR 28\u2013199) in PE versus 20 copies\/mL (IQR 9\u201381) for NP participants (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.047). ks-et1 and t-cfDNA showed non-significant increases in PE. Fractional ks-et quantities normalised to t-cfDNA did not differ between groups. Urinary creatinine levels were higher in the PE group (10.9 mmol\/L (IQR 4.1\u201315.3) versus 3.9 mmol\/L (IQR 2.3\u20135.6),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005). Urine creatinine demonstrated the highest AUC (0.76, 95% CI 0.59\u20130.92).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This exploratory study found that quantification of urinary ks-cfDNA was feasible and that absolute quantities of ks-cfDNA markers ks-et2 and ks-et3 were elevated in PE. Consistent with previous studies, urinary creatinine was a good predictor of PE and outperformed ks-cfDNA in discriminating between preeclamptic and normotensive pregnancies. Further studies are needed to determine the clinical utility and predictive ability of ks-cfDNA in PE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0359105","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:24:31Z","timestamp":1790702671000},"page":"e0359105","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of urinary kidney-specific cell-free DNA in preeclampsia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7659-6264","authenticated-orcid":true,"given":"Vanessa C.","family":"Heron","sequence":"first","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]},{"name":"Mercy Hospital for Women","place":["Heidelberg, Victoria, Australia"],"department":["Department of Obstetrics"]},{"name":"University of Melbourne","place":["Parkville, Victoria, Australia"],"department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Whitlam","sequence":"additional","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]},{"name":"University of Melbourne","place":["Parkville, Victoria, Australia"],"department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Murray","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research","place":["Darlinghurst, New South Wales, Australia"]},{"name":"University of Newcastle","place":["Callaghan, New South Wales, Australia"],"department":["School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Boulter","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research","place":["Darlinghurst, New South Wales, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mount","sequence":"additional","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]},{"name":"University of Melbourne","place":["Parkville, Victoria, Australia"],"department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-7779","authenticated-orcid":true,"given":"Suet-Wan","family":"Choy","sequence":"additional","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]},{"name":"Mercy Hospital for Women","place":["Heidelberg, Victoria, Australia"],"department":["Department of Obstetrics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Katerelos","sequence":"additional","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Paizis","sequence":"additional","affiliation":[{"name":"Austin Health","place":["Heidelberg, Victoria, Australia"],"department":["Department of Nephrology"]},{"name":"Mercy Hospital for Women","place":["Heidelberg, Victoria, Australia"],"department":["Department of Obstetrics"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"1","key":"pone.0359105.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: A systematic review","volume":"170","author":"E Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"pone.0359105.ref002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"MA Brown","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"pone.0359105.ref003","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/jcm9051480","article-title":"The use of donor-derived cell-free DNA for assessment of allograft rejection and injury status","volume":"9","author":"C Thongprayoon","year":"2020","journal-title":"J Clin Med"},{"issue":"17","key":"pone.0359105.ref004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/epi-2023-0255","article-title":"Cell-free DNA as a plausible biomarker of chronic kidney disease","volume":"15","author":"TA Berezina","year":"2023","journal-title":"Epigenomics"},{"issue":"3","key":"pone.0359105.ref005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0000000000003393","article-title":"The monitoring of donor-derived cell-free DNA in kidney transplantation","volume":"105","author":"EJ Filippone","year":"2021","journal-title":"Transplantation"},{"issue":"8","key":"pone.0359105.ref006","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"A Kustanovich","year":"2019","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"pone.0359105.ref007","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0000000000004482","article-title":"Understanding donor-derived cell-free DNA in kidney transplantation: An overview and case-based guide for clinicians","volume":"107","author":"AS Graver","year":"2023","journal-title":"Transplantation"},{"issue":"9076","key":"pone.0359105.ref008","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"YM Lo","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"pone.0359105.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200360","article-title":"Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation","volume":"13","author":"T Rafaeli-Yehudai","year":"2018","journal-title":"PLoS One"},{"key":"pone.0359105.ref010","doi-asserted-by":"crossref","first-page":"1191163","DOI":"10.3389\/fmed.2023.1191163","article-title":"Use of cell-free signals as biomarkers for early and easy prediction of preeclampsia","volume":"10","author":"J Gekas","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"pone.0359105.ref011","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2017.12","article-title":"Cell-free DNA: The role in pathophysiology and as a biomarker in kidney diseases","volume":"20","author":"P Celec","year":"2018","journal-title":"Expert Rev Mol Med"},{"key":"pone.0359105.ref012","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How many cell types are in the kidney and what do they do?","volume":"84","author":"MS Balzer","year":"2022","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"pone.0359105.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218548","article-title":"High levels of cell-free DNA accurately predict late acute kidney injury in patients after cardiac surgery","volume":"14","author":"J Merkle","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"pone.0359105.ref014","doi-asserted-by":"crossref","first-page":"2273422","DOI":"10.1080\/0886022X.2023.2273422","article-title":"Cell-free DNA predicts all-cause mortality of sepsis-induced acute kidney injury","volume":"46","author":"F Xu","year":"2024","journal-title":"Ren Fail"},{"issue":"1","key":"pone.0359105.ref015","article-title":"Serum cell-free DNA and progression of diabetic kidney disease: A prospective study","volume":"8","author":"X Li","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"pone.0359105.ref016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mefs.2016.04.001","article-title":"Maternal urinary cell free fetal DNA in relation to gestational age","volume":"21","author":"MM Shaban","year":"2016","journal-title":"Middle East Fertil Soc J"},{"issue":"10","key":"pone.0359105.ref017","article-title":"High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing","volume":"7","author":"NBY Tsui","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"pone.0359105.ref018","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5694\/mja2.52312","article-title":"A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline","volume":"220","author":"R Shanmugalingam","year":"2024","journal-title":"Med J Aust"},{"issue":"6","key":"pone.0359105.ref019","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"9","key":"pone.0359105.ref020","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.70210","article-title":"From DNA methylation microarray to digital PCR: A stepwise strategy for tissue specific cfDNA biomarker development","volume":"40","author":"DH Murray","year":"2026","journal-title":"J Clin Lab Anal"},{"key":"pone.0359105.ref021","doi-asserted-by":"crossref","unstructured":"Ranjit S, Boulter NR, Murray DH. Methylation-based cell-free DNA assay for early detection and monitoring of AKI. Poster\/Saturday: AKI: Clinical Diagnostics and Biomarkers; Houston, Texas; 2025. Epub ahead of print October 2025. https:\/\/doi.org\/10.1681\/ASN.20256gp8w09h","DOI":"10.1681\/ASN.20256gp8w09h"},{"issue":"2","key":"pone.0359105.ref022","article-title":"New method to preserve the original proportion and integrity of urinary cell-free DNA","volume":"33","author":"P Li","year":"2019","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"pone.0359105.ref023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiology.181.1.1887021","article-title":"In utero analysis of fetal growth: A sonographic weight standard","volume":"181","author":"FP Hadlock","year":"1991","journal-title":"Radiology"},{"issue":"1","key":"pone.0359105.ref024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/uog.19073","article-title":"Fetal Medicine Foundation fetal and neonatal population weight charts","volume":"52","author":"KH Nicolaides","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"pone.0359105.ref025","doi-asserted-by":"crossref","first-page":"2408146","DOI":"10.1080\/15592294.2024.2408146","article-title":"A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury","volume":"19","author":"R You","year":"2024","journal-title":"Epigenetics"},{"issue":"9","key":"pone.0359105.ref026","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.clinbiochem.2017.02.017","article-title":"Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA","volume":"50","author":"THT Cheng","year":"2017","journal-title":"Clin Biochem"},{"key":"pone.0359105.ref027","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1258\/acb.2010.090290","article-title":"Increases in urinary creatinine and blood pressure during early pregnancy in pre-eclampsia","volume":"47","author":"K Kuromoto","year":"2010","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"pone.0359105.ref028","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1442-200X.2006.02207.x","article-title":"Spot urinary creatinine excretion in pervasive developmental disorders","volume":"48","author":"P Whiteley","year":"2006","journal-title":"Pediatr Int"},{"issue":"4","key":"pone.0359105.ref029","first-page":"155","article-title":"Renal lesions in the hypertensive syndromes of pregnancy: Immunomorphological and ultrastructural studies in 114 cases","volume":"13","author":"D Nochy","year":"1980","journal-title":"Clin Nephrol"},{"issue":"8","key":"pone.0359105.ref030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2215\/CJN.12811213","article-title":"Association of preeclampsia with podocyte turnover","volume":"9","author":"ME Penning","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0359105.ref031","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopha.2018.10.082","article-title":"Preeclampsia: A close look at renal dysfunction","volume":"109","author":"H Moghaddas Sani","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"pone.0359105.ref032","doi-asserted-by":"crossref","unstructured":"Dines V, Suvakov S, Kattah A, et al. Preeclampsia and the kidney: Pathophysiology and clinical implications. In: Prakash YS, editor. Comprehensive physiology. Wiley. p. 4231\u201367.","DOI":"10.1002\/cphy.c210051"},{"key":"pone.0359105.ref033","doi-asserted-by":"crossref","first-page":"1130112","DOI":"10.3389\/fmed.2023.1130112","article-title":"Evidence of kidney injury in preeclampsia: Increased maternal and urinary levels of NGAL and KIM-1 and their enhanced expression in proximal tubule epithelial cells","volume":"10","author":"Y Wang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"pone.0359105.ref034","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00509.2016","article-title":"Longitudinal characterization of renal proximal tubular markers in normotensive and preeclamptic pregnancies","volume":"312","author":"E Codsi","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"12","key":"pone.0359105.ref035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ajh\/hpt187","article-title":"Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome","volume":"26","author":"ML Miranda","year":"2013","journal-title":"Am J Hypertens"},{"issue":"5","key":"pone.0359105.ref036","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: Pathogenesis, novel diagnostics and therapies","volume":"15","author":"EA Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"pone.0359105.ref037","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preghy.2022.05.009","article-title":"Amount of proteinuria as associated with severity classification of pregnant women with preeclampsia","volume":"29","author":"T Okamoto","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"11","key":"pone.0359105.ref038","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women","volume":"20","author":"M Haghiac","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"pone.0359105.ref039","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501332","article-title":"Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance","volume":"2","author":"S Nishimoto","year":"2016","journal-title":"Sci Adv"},{"issue":"9","key":"pone.0359105.ref040","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/pd.3919","article-title":"A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI","volume":"32","author":"NL Vora","year":"2012","journal-title":"Prenat Diagn"},{"issue":"3","key":"pone.0359105.ref041","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.jrn.2023.01.005","article-title":"Association of body mass index and acute kidney injury incidence and outcome: A systematic review and meta-analysis","volume":"33","author":"J Lan","year":"2023","journal-title":"J Ren Nutr"},{"issue":"1","key":"pone.0359105.ref042","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2013.12.022","article-title":"Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey","volume":"233","author":"J Jylh\u00e4v\u00e4","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"pone.0359105.ref043","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"H Zeisler","year":"2016","journal-title":"N Engl J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:24:41Z","timestamp":1790702681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359105"}},"subtitle":[],"editor":[{"given":"Maria Lourdes","family":"Gonzalez Suarez","sequence":"first","affiliation":[{"name":"Mayo Clinic Rochester","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359105","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}